Study:
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Rationale:
n/a
Purpose:
Study purpose:
The disease course of idiopathic pulmonary fibrosis (IPF) is variable. During the course of
the disease some patients will get better, some will stay the same, and others will get
worse. Currently doctors do not have any way to predict an individual patients disease
course. The purpose of this study is to determine if `biomarkers` such as proteins or genes
isolated at the time of diagnosis can be used to predict the disease course. These
`biomarkers` will be obtained from samples of blood, from a procedure call a bronchoscopy,
and in some patients from extra tissue obtained by a surgical lung biopsy.
Study Status: Completed
Recruiting:
n/a
| Condition |
Intervention |
Phase |
|
Idiopathic Pulmonary Fibrosis |
n/a |
N/A |
Verified by
University of Michigan
November, 2009
Sponsored by: University of Michigan
Information provided by: University of Michigan
ClinicalTrials.gov identifier: NCT01071707
Study Type: Interventional
Study Design: Observational Model: Case-Only, Time Perspective: Prospective
Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States
Herbert Reynolds, MD., Study Director
Fernando J Martinez, MD,MS., Principal Investigator
Galen B Toews, MD., Principal Investigator
Kevin R Flaherty, MD, MS., Principal Investigator